Home
Account
Research Tools & Data
Educate
Contribute
News
ETFs
Sectors
About
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Economic Calendar
Chart School
Tutorials
Learning Center
Submit Article
Join Blog Network
Chat Rooms
Rate Broker
Rate Software
About Us
Contact Us
Advertise With Us
Terms and Conditions
Enter Symbol
Overview
Community Research
Stock Sentiment
Whisper Estimates
Enter Estimates
Company Profile
Technical Charts
Competitors
Analyst Ratings
Analyst Estimates
Sales Estimates
Related News
Blog Articles
Press Releases
Message Board
Option Chain
Financial Ratios
Technicals
SEC Filings
Sector: Medical
Emisphere Technologies, Inc. (NASDAQ: EMIS)
3m
6m
1y
2y
Ranking History
This Week
Last Week
Two Weeks Back
Three Weeks Back
Please login to view our current ranking data
Click here to login
No Information
No Information
No Information
Disclaimer
Headlines
Blog Articles
Press Releases
SEC
Emisphere Technologies to Present at the New York Society of Security Analysts' 13th Annual Biotech & Specialty Pharma Investment Conference
Nov 24, 2009 09:05 AM |
EMIS
NYSSA Presents 13th Annual Biotech and Specialty Pharmaceuticals Conference
Nov 20, 2009 03:02 PM |
CYCC
,
ECTE
,
EMIS
,
INO
,
PVCT
Emisphere Technologies Announces Financial and Operational Results for the Third Quarter and First Nine Months of 2009
Nov 09, 2009 08:45 AM |
EMIS
Emisphere Technologies Appoints Tim Rothwell to the Board of Directors
Nov 05, 2009 04:29 PM |
EMIS
,
SNY
Emisphere Technologies Announces Third Quarter 2009 Conference Call
Nov 04, 2009 08:45 AM |
EMIS
Interim Study Data Demonstrate Eligen(R) B12 Oral Formulation Achieves Comparable Results to B12 Injection
Nov 02, 2009 04:07 PM |
EMIS
Study Results: Novel Oral PTH Formulation Using Emisphere's Eligen(R) Technology Showed Potential Therapeutical Advantages to Available Injectable PTH in Postmenopausal Osteoporotic Women
Oct 20, 2009 09:39 AM |
EMIS
,
NVS
Study Results Suggest Oral Salmon Calcitonin Using Eligen(R) Drug Delivery Technology May Reduce Cartilage and Bone Degradation in Osteoarthritis
Oct 15, 2009 09:30 AM |
EMIS
,
NVS
StockPreacher.com Issues Trading Outlook for MDRNA Inc.
Oct 14, 2009 06:51 AM |
AMGN
,
BIIB
,
EMIS
,
JNJ
Emisphere Technologies Introduces First Commercially Available Product, Oral Eligen(R) B12
Oct 08, 2009 08:45 AM |
EMIS
More..
More..
Emisphere Technologies Announces Closing of $4 Million Registered Direct Offering and $4 Million Private Placement
Aug 21, 2009 05:50 PM |
EMIS
,
RODM
Emisphere Technologies to Raise $4 Million in Registered Direct Offering and Additional $4 Million in Private Placement
Aug 19, 2009 10:53 AM |
EMIS
,
RODM
Emisphere Technologies Announces Financial and Operational Results for the Second Quarter and First Six Months of 2009
Aug 11, 2009 08:14 AM |
EMIS
Emisphere Technologies Announces Second Quarter 2009 Conference Call
Aug 07, 2009 09:26 AM |
EMIS
Molecular Insight Pharmaceuticals, Inc. Appoints Charles H. Abdalian, Jr. Vice President of Finance, CFO
Aug 05, 2009 10:04 AM |
EMIS
,
MIPI
Emisphere’s SNAC Carrier Achieves GRAS Status for Use with Nutrients Added to Foods and Dietary Supplements
Jul 28, 2009 08:21 AM |
EMIS
Emisphere Technologies, Inc. and Syracuse University Enter Research Agreement to Test Oral Drug Delivery Systems
Jun 22, 2009 08:43 AM |
EMIS
Emisphere Technologies, Inc. Receives NASDAQ Panel Decision
Jun 08, 2009 10:39 AM |
EMIS
Emisphere Technologies Announces the Completion of Enrollment in Second Phase III Study for Oral Osteoarthritis Treatment Utilizing Proprietary Eligen® Technology
Jun 01, 2009 08:52 AM |
EMIS
Emisphere Technologies Reports Encouraging Data from Independent Clinical Study Assessing the Effects of Oral GLP-1 and PYY3-36, Combined with Eligen® Technology on Appetite Suppression
May 26, 2009 08:07 AM |
EMIS
More..
Form 4 EMISPHERE TECHNOLOGIES For: Nov 05 Filed by: ROTHWELL TIMOTHY G (10K)
Nov 12, 2009 07:19 AM
Form 3 EMISPHERE TECHNOLOGIES For: Nov 05 Filed by: ROTHWELL TIMOTHY G (10K)
Nov 12, 2009 07:15 AM
Form 4 MHR ADVISORS LLC For: Aug 21 (10K)
Aug 25, 2009 11:06 PM
Form 4 HARKEY JOHN D JR For: May 15 (10K)
May 19, 2009 10:27 PM
Form 4 Novinski Michael V For: May 15 (10K)
May 19, 2009 10:25 PM
Form 4 EMISPHERE TECHNOLOGIES For: May 15 Filed by: RACHESKY MARK H MD (10K)
May 19, 2009 10:25 PM
Form 4 MHR ADVISORS LLC For: Dec 31 (10K)
Jan 05, 2009 09:47 PM
Form 4 EMISPHERE TECHNOLOGIES For: Aug 18 Filed by: Riley Gary (10K)
Aug 20, 2008 07:58 PM
Form 4 EMISPHERE TECHNOLOGIES For: Aug 13 Filed by: RACHESKY MARK H MD (10K)
Aug 15, 2008 09:32 PM
Form 4 EMISPHERE TECHNOLOGIES For: Aug 13 Filed by: HARKEY JOHN D JR (10K)
Aug 15, 2008 05:16 PM
More..
Analyst Ratings
More Details
Sentiment Survey
Avg. Short Term
Avg. Long Term
Avg. Grade
More Details
Share Performance
Period
EMIS
Compare to S&P
YTD
-15.19 %
-29.81 %
4 Weeks
6.35 %
5.20 %
12 Weeks
-28.72 %
-32.80 %
More...
Financial Ratios
Earnings Performance
EPS Growth in Last Quarter:
31.25 %
EPS Growth in Last Year:
35.29 %
Sales Growth in Last Quarter:
-93.51 %
Sales Growth in Last Quarter:
-98.33 %
More...
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##
Fundamental data is provided by
Zacks Investment Research
, market data is provided by
AlphaTrade.
, and Commentary and Press Releases provided by
Quotemedia
